In the next few months when you go to the doctor, do not be shocked if the doctor does not suggest old fashion diet and exercise to lose excess weight, but instead medicine.

The Food and Drug Administration, FDA, has granted approval to the new obesity drug, Contrave.

Contrave is an investigational solution for treating obesity. It combines two components – naltrexone SR and bupropion SR. The combination of the two drugs acts complementary in the central nervous system and they are believed to address the biological and behavioral drivers of obesity.

The average person is supposed to lose five percent of their body fat when taking the drug.

Contrave: Contrave Obesity Drug Gets FDA Approval | Long Island Press